Answers from the Lab

Apr 07 2025 347 ep. 13 mins 1.2k
Answers from the Lab Podcast artwork

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.

  Health & Fitness  Science
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP, R.Ph.

Apr 07 2025 15 mins  
Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after organ transplants. Optimal doses can vary by patient ethnicity and are key to successful transplantation.Speaker 3: (00:32) Could you provide us a with little bit about your background and yourself? Speaker 3: (03:45) Will you please provi

Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

Apr 02 2025 11 mins  
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence, to discuss liquid biopsy cancer testing. Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that

The Emergence of Retail Health: Bill Morice, M.D., Ph.D.

Mar 26 2025 14 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the evolution of retail health. They cover several key topics, including:The emergence of retail health locations.Three types of care that are well

Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D.

Mar 12 2025 14 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss infectious disease activity around the nation. They cover: The high prevalence of influenza A, avian influenza, measles, and COVID-19. Reliable re

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

Feb 26 2025 14 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI). Topics include: The advantages and challenges of new t

Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.

Feb 12 2025 16 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, for a conversation about quality management. Specifically, they discuss: The benefit of investing in quality management for patients, staff, and the organizat

Importance of Monitoring Business Trends in Diagnostics: Bill Morice, M.D., Ph.D.

Jan 29 2025 18 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss recent business trends in diagnostics and why it is important for pathologists to stay informed about these trends. Their conversation covers: Wh

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.

Jan 20 2025 19 mins  
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease.Speaker 3: (00:32) Would you mind telling us a little bit about yourself and your background? Speaker 3:

Innovations Set to Shape the Industry in 2025: Bill Morice, M.D., Ph.D.

Jan 15 2025 13 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss Dr. Morice’s recent article in Becker’s Hospital Review, “Nine Developments Predicted to Shape Laboratory Medicine and Diagnostics in 2025,

Benefits of Automation in the Laboratory: Erin Graf, Ph.D.

Jan 08 2025 12 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Erin Graf, Ph.D., co-director of Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona, to discuss benefits of automation in the laboratory. Topics of discussion include:Specific examples of how th